Fong Clinical Risk Score for Colorectal Cancer Recurrence
The Fong Clinical Risk Score estimates recurrence risk after resection of colorectal liver metastases using five adverse prognostic factors.
Indications d'utilisation
Used for patients with resectable colorectal liver metastases to estimate recurrence risk and guide selection for hepatic resection or, in trials, liver transplantation. High scores (3–4) correlate with significantly worse disease-free survival after liver transplant compared with scores 1–2 (P = 0.044) 1 [Level II evidence]. Clinically useful for prognostic stratification, counseling, and comparing expected outcomes across management strategies.
Informations et précautions
Uses five adverse factors (node‑positive primary, disease-free interval <12 months, >1 liver metastasis, largest metastasis >5 cm, CEA >200). More factors = higher recurrence risk. Insights: simple and widely used for colorectal liver metastases; strongest utility is surgical decision-making. Cautions: limited discrimination vs modern models; omits molecular markers; underperforms newer scores (e.g., CERR outperformed it 1 [Level II evidence]); may misclassify patients with favorable biology.